FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Last trade - 00:00- £203.10m
- £210.89m
REG - Faron Pharma. Oy - First Patient Dosed in Ph 2 of the BEXMAB Trial
AnnouncementRCS - Faron Pharma. Oy - Presentation at J.P. Morgan Healthcare Conference
AnnouncementREG - Faron Pharma. Oy - Faron’s Financial Calendar for 2024
AnnouncementREG - Faron Pharma. Oy - Phase 1 BEXMAB data presented at ASH
AnnouncementRCS - Faron Pharma. Oy - MATINS Trial in Cell Reports Medicine
AnnouncementREG - Faron Pharma. Oy - Grant of options
AnnouncementREG - Faron Pharma. Oy - Faron Initiates Phase 2 Part of BEXMAB Study
AnnouncementRCS - Faron Pharma. Oy - Faron to present data from BEXMAB study at ASH
AnnouncementREG - AIM - AIM Notice - 30/10/2023
AnnouncementREG - Faron Pharma. Oy - Manager's transactions
AnnouncementREG - Faron Pharma. Oy - Results of Placing
AnnouncementREG - Faron Pharma. Oy - Exercise of options
AnnouncementREG - Faron Pharma. Oy - Proposed Issue and Placing
AnnouncementREG - Faron Pharma. Oy - Faron Announces Positive BEXMAB Study Update
AnnouncementRCS - Faron Pharma. Oy - Faron to host webcast on new BEXMAB study data
AnnouncementREG - Faron Pharma. Oy - Board Changes
AnnouncementREG - Faron Pharma. Oy - Results of EGM
AnnouncementREG - Faron Pharma. Oy - Faron Appoints Interim Chief Medical Officer
AnnouncementREG - AIM - AIM Notice - 11/09/2023
Announcement